202 related articles for article (PubMed ID: 26458100)
1. Signalling in inflammatory skin disease by AP-1 (Fos/Jun).
Uluçkan Ö; Guinea-Viniegra J; Jimenez M; Wagner EF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S44-9. PubMed ID: 26458100
[TBL] [Abstract][Full Text] [Related]
2. Targeting inflammation by modulating the Jun/AP-1 pathway.
Schonthaler HB; Guinea-Viniegra J; Wagner EF
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i109-12. PubMed ID: 21339212
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-17A signalling in psoriasis and associated bone loss.
Uluçkan Ö; Wagner EF
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
[TBL] [Abstract][Full Text] [Related]
4. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
[TBL] [Abstract][Full Text] [Related]
6. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
7. TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.
Guinea-Viniegra J; Zenz R; Scheuch H; Hnisz D; Holcmann M; Bakiri L; Schonthaler HB; Sibilia M; Wagner EF
Genes Dev; 2009 Nov; 23(22):2663-74. PubMed ID: 19933155
[TBL] [Abstract][Full Text] [Related]
8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
9. Targeting miR-21 to treat psoriasis.
Guinea-Viniegra J; Jiménez M; Schonthaler HB; Navarro R; Delgado Y; Concha-Garzón MJ; Tschachler E; Obad S; Daudén E; Wagner EF
Sci Transl Med; 2014 Feb; 6(225):225re1. PubMed ID: 24574341
[TBL] [Abstract][Full Text] [Related]
10. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
Wagner EF
Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i86-88. PubMed ID: 19995753
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.
Zenz R; Eferl R; Kenner L; Florin L; Hummerich L; Mehic D; Scheuch H; Angel P; Tschachler E; Wagner EF
Nature; 2005 Sep; 437(7057):369-75. PubMed ID: 16163348
[TBL] [Abstract][Full Text] [Related]
12. Influence of genistein on c-Jun, c-Fos and Fos-B of AP-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro.
Jurzak M; Adamczyk K
Acta Pol Pharm; 2013; 70(2):205-13. PubMed ID: 23614275
[TBL] [Abstract][Full Text] [Related]
13. Fos and jun proteins are specifically expressed during differentiation of human keratinocytes.
Mehic D; Bakiri L; Ghannadan M; Wagner EF; Tschachler E
J Invest Dermatol; 2005 Jan; 124(1):212-20. PubMed ID: 15654976
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
15. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.
Zenz R; Eferl R; Scheinecker C; Redlich K; Smolen J; Schonthaler HB; Kenner L; Tschachler E; Wagner EF
Arthritis Res Ther; 2008; 10(1):201. PubMed ID: 18226189
[TBL] [Abstract][Full Text] [Related]
16. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic beta cells.
Glauser DA; Schlegel W
FASEB J; 2007 Oct; 21(12):3240-9. PubMed ID: 17504975
[TBL] [Abstract][Full Text] [Related]
17. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
18. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion.
Gillardon F; Eschenfelder C; Uhlmann E; Hartschuh W; Zimmermann M
Oncogene; 1994 Nov; 9(11):3219-25. PubMed ID: 7936645
[TBL] [Abstract][Full Text] [Related]
20. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
